Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Solid Biosciences Inc.
Market Cap
$681.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$681.02M
Operating Margin
-550.33%
TTM Avg
-849.94%
3Y Avg
-1127.37%
5Y Avg
-1259.40%
Market Cap
$685.49M
Operating Margin
-4908.21%
TTM Avg
-3903.83%
3Y Avg
-2635.01%
5Y Avg
-1845.37%
Market Cap
$673.41M
Operating Margin
15.26%
TTM Avg
16.07%
3Y Avg
9.54%
5Y Avg
2.83%
Market Cap
$691.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$693.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$693.61M
Operating Margin
-504.09%
TTM Avg
-303.01%
3Y Avg
-1281.34%
5Y Avg
-1033.23%
Market Cap
$694.79M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$666.95M
Operating Margin
317.06%
TTM Avg
-14996.68%
3Y Avg
-12629.31%
5Y Avg
-15360.40%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | $681.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Verastem, Inc. (VSTM)vs › | $681.02M | -550.33% | -849.94% | -1127.37% | -1259.40% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 15.26% | 16.07% | 9.54% | 2.83% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -504.09% | -303.01% | -1281.34% | -1033.23% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -21.60% | -15.14% | -11.45% | -3.99% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
| Annexon, Inc. (ANNX)vs › | $660.29M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -411.44% |
| 2022-03-31 | -1318.03% |
| 2021-12-31 | -591.38% |
| 2021-09-30 | -509.78% |
| 2021-06-30 | -519.89% |
| 2021-03-31 | -506.33% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-03-31 | 0.00% |
